MENU
+Compare
JNJ
Stock ticker: NYSE
AS OF
Jul 3, 02:00 PM (EDT)
Price
$155.91
Change
+$0.35 (+0.22%)
Capitalization
380.22B

JNJ Johnson & Johnson Forecast, Technical & Fundamental Analysis

Johnson & Johnson is the world's largest and most diverse healthcare firm... Show more

JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for JNJ with price predictions
Jul 02, 2025

JNJ in upward trend: price expected to rise as it breaks its lower Bollinger Band on June 18, 2025

JNJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 45 cases where JNJ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where JNJ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 01, 2025. You may want to consider a long position or call options on JNJ as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for JNJ just turned positive on July 01, 2025. Looking at past instances where JNJ's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

JNJ moved above its 50-day moving average on July 01, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JNJ advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 245 cases where JNJ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day moving average for JNJ crossed bearishly below the 50-day moving average on June 26, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The 50-day moving average for JNJ moved below the 200-day moving average on June 02, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JNJ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.528) is normal, around the industry mean (5.632). P/E Ratio (30.342) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.968) is also within normal values, averaging (3.004). Dividend Yield (0.030) settles around the average of (0.161) among similar stocks. P/S Ratio (4.744) is also within normal values, averaging (3.643).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JNJ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

JNJ is expected to report earnings to fall 3.25% to $2.68 per share on July 16

Johnson & Johnson JNJ Stock Earnings Reports
Q2'25
Est.
$2.68
Q1'25
Beat
by $0.19
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.23
Q2'24
Beat
by $0.10
The last earnings report on April 15 showed earnings per share of $2.77, beating the estimate of $2.58. With 3.48M shares outstanding, the current market capitalization sits at 380.22B.
A.I.Advisor
published Dividends

JNJ paid dividends on June 10, 2025

Johnson & Johnson JNJ Stock Dividends
А dividend of $1.30 per share was paid with a record date of June 10, 2025, and an ex-dividend date of May 27, 2025. Read more...
A.I. Advisor
published General Information

General Information

an investment holding company with interests in health care products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
One Johnson and Johnson Plaza
Phone
+1 732 524-0400
Employees
131900
Web
https://www.jnj.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MTUM236.900.09
+0.04%
iShares MSCI USA Momentum Factor ETF
IBID25.88-0.01
-0.03%
iShares iBonds Oct 2027 Term Tips ETF
SPAM32.80-0.04
-0.13%
Themes Cybersecurity ETF
FLCH21.62-0.14
-0.64%
Franklin FTSE China ETF
SCHQ31.63-0.26
-0.82%
Schwab Long-Term US Treasury ETF

JNJ and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
-0.23%
PFE - JNJ
59%
Loosely correlated
+1.12%
NVS - JNJ
56%
Loosely correlated
+0.58%
GSK - JNJ
52%
Loosely correlated
-1.13%
AMGN - JNJ
43%
Loosely correlated
+2.18%
ABBV - JNJ
43%
Loosely correlated
+2.76%
More